+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Ophthalmic Lasers Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5175936
  • Report
  • August 2020
  • Region: Global
  • 114 Pages
  • Mordor Intelligence


  • IRIDEX Corporation
  • Lumenis
  • Quantel Medical
Factors that are responsible for the growth of the ophthalmic lasers market include a high prevalence of ophthalmic disorders, increasing initiatives to control visual impairment, and increasing regulatory approvals for ophthalmic lasers.
  • There has been and continues to be a considerable amount of research activity in the ophthalmic lasers arena. Hence, several number of eye lasers are receiving regulatory approvals, which help in driving the ophthalmic lasers market.
  • In September 2019, SCHWIND eye-tech-solutions launched the ATOS femtosecond laser, with capabilities for both femtoLASIK and innovative lenticule extraction with the SmartSight technology, in Europe. Thus, the increase in regulatory approvals helps in driving the growth of the ophthalmic lasers market.

Key Market Trends

Refractive Error Corrections are Expected to Hold the Highest Revenue in the Application Segment

In the application segment of the ophthalmic lasers market, refractive error corrections are projected to have the largest revenue during the forecast period. This is majorly due to factors, such as the escalating number of refractive error cases among both children and adults. Furthermore, an increase in the application of femtosecond lasers in refractive error surgeries is helping the growth of this segment.
  • Refractive error is a type of vision problem that makes it hard to see clearly. Nearsightedness (myopia), farsightedness (hyperopia), astigmatism, and presbyopia are the four different types of refractive errors.
  • According to the NIH National Eye Institute, more than 11 million Americans have common vision problems that can be corrected with the use of prescriptive eyewear, such as glasses or contact lenses. More than 150 million Americans use corrective eyewear, spending more than USD 15 billion on eyewear each year.

North America Dominates the Market and is Expected to do Same during the Forecast Period

Currently, North America dominates the market for ophthalmic lasers and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share, owing to the increasing incidence rates of ophthalmic problems and increasing healthcare expenditure in the country, as well as the development of sophisticated healthcare infrastructure in the country.

Competitive Landscape

The ophthalmic lasers market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising incidence of ophthalmic cases and increasing geriatric population, few other smaller players are expected to enter the market. Some of the major players of the market are Alcon Laboratories Inc. (Novartis AG), Johnson & Johnson Surgical Vision Inc., Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.), Ellex Medical Lasers Limited, and IRIDEX Corporation, among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • IRIDEX Corporation
  • Lumenis
  • Quantel Medical

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Ophthalmic Disorders
4.2.2 Increasing Regulatory Approvals for Ophthalmic Lasers
4.2.3 Increasing Initiatives to Control Visual Impairments
4.3 Market Restraints
4.3.1 Huge Cost Associated with Ophthalmic Laser Therapies
4.3.2 Reduced Availability of Skilled Practitioners
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Diode Lasers
5.1.2 Femtosecond Lasers
5.1.3 Excimer Lasers
5.1.4 Nd:YAG Lasers
5.1.5 Other Products
5.2 By Application
5.2.1 Glaucoma
5.2.2 Cataract Removal
5.2.3 Refractive Error Corrections
5.2.4 Diabetic Retinopathy
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Eye Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Alcon Laboratories Inc. (Novartis AG)
6.1.2 Johnson & Johnson Surgical Vision Inc.
6.1.3 Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.)
6.1.4 Ellex Medical Lasers Limited
6.1.5 IRIDEX Corporation
6.1.7 Quantel Medical
6.1.8 SCHWIND eye-tech-solutions
6.1.9 Lumenis
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Alcon Laboratories Inc. (Novartis AG)
  • Johnson & Johnson Surgical Vision Inc.
  • Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.)
  • Ellex Medical Lasers Limited
  • IRIDEX Corporation
  • Quantel Medical
  • SCHWIND eye-tech-solutions
  • Lumenis
Note: Product cover images may vary from those shown